For mass tort firms, growth is not simply a question of generating more inquiries. The harder operational question is whether the firm can identify which claimants deserve intake time, follow-up resources, and attorney review before volume overwhelms the system. That...
Mass tort firms are navigating two competing realities: (1) claimant volume can surge overnight, and (2) eligibility often hinges on detailed exposure, product usage, medical timelines, and documentation that don’t fit neatly into a single “yes/no” form. That mismatch...
In today’s digital age, your contact form is one of the highest-intent moments on your website: a prospective client is interested enough to reach out, but not committed enough to fight through friction, confusion, or errors. Below are six strategic ways to improve...
A Year That Redefined the Mass Tort Playbook Introduction The mass tort landscape in 2025 marked a clear turning point for plaintiffs firms. Traditional assumptions about volume, MDL momentum, and broad sign-ups were challenged as courts tightened standards, new...
Mass tort litigation often involves large groups of people affected by the same product, medication, environmental exposure, or corporate negligence. While these cases can impact thousands of individuals, many potential claimants are unaware they may have legal...